Urate-lowering therapy modifies associations between urinary urate and kidney outcome. [PDF]
Takata T +6 more
europepmc +1 more source
Uric Acid as a Redox Switch in Gout: Linking Xanthine Oxidoreductase-Derived ROS, NLRP3 Inflammasome Activation and Emerging Ferroptotic Mechanisms. [PDF]
Petrov PP +4 more
europepmc +1 more source
Guideline Concordance and Documentation of Allopurinol Initiation Across Clinical Specialties: A Three-Year Retrospective Evaluation. [PDF]
Aboabat A +12 more
europepmc +1 more source
Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation. [PDF]
Borghi C, Fogacci F, Cicero AFG.
europepmc +1 more source
Locus-specific stratification and prioritization unveil genetic risk mechanism underlying complex diseases. [PDF]
Zhang J +10 more
europepmc +1 more source
Recent advances in research on the association between paediatric hyperuricaemia and bone health. [PDF]
Zhang T, Li X, Liu X.
europepmc +1 more source
Statement of Retraction: Cynarin suppresses gouty arthritis induced by monosodium urate crystals. [PDF]
europepmc +1 more source
6'‑O‑Caffeoylarbutin attenuates experimental hyperuricemia by regulating renal and intestinal urate transport, intestinal barrier integrity, and gut microbiota. [PDF]
Yu X +11 more
europepmc +1 more source

